Prof. Semen ÖNDER

Publication Network

Articles 82

1. Accuracy of Intraoperative Sentinel Lymph Node Evaluation by Imprint Cytology in Breast Cancer: A 12-Year Single Center Experience With 2,528 Patients

Bayram A., BAGBUDAR S., KARAOĞLAN Ç., Sayar E., Mollavelioğlu B., Tükenmez M., et al.

European Journal of Breast Health , vol.21, no.4, pp.333-338, 2025 (ESCI, Scopus, TRDizin)

2. Comparison of clinical and histopathological characteristics of differentiated thyroid cancers in euthyroid nodular goiter and Graves’ disease

Güden İ., Karataş İ., İşcan A. Y., Yegen G., Önder S., Aksakal N., et al.

Endocrine Connections , vol.14, no.8, pp.1-8, 2025 (Scopus)

3. Carbon dye versus indocyanine green for sentinel lymph node mapping in endometrial cancer: a prospective dual-center study

Minareci Y., Sozen H., Bayram A., Hacioglu B. A., Yuvanc H. O., Murdan R., et al.

International Journal of Gynecological Cancer , vol.35, no.6, 2025 (SCI-Expanded)

4. Estrogen receptor positivity in stromal cells of the tumor bed predicts the response to neoadjuvant chemotherapy for breast carcinoma

BAYRAM A., Bagbudar S., KARANLIK H., CABIOĞLU N., AYDINER A., ÖNDER S., et al.

BREAST CANCER RESEARCH AND TREATMENT , 2025 (SCI-Expanded)

5. ⁶⁸Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism

Kuyumcu S., Denizmen D., Has-Simsek D., Poyanli A., Uzum A. K., Buyukkaya F., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.51, no.13, pp.3912-3923, 2024 (SCI-Expanded, Scopus)

6. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer

Cabioglu N., Onder S., Karatay H., Bayram A., Oner G., Tukenmez M., et al.

Cancers , vol.16, no.13, 2024 (SCI-Expanded) Sustainable Development

7. THE ROLE OF BETA-CATENIN AND FOXP1 IN THE PATHOGENESIS OF POLYPOID ENDOMETRIOSIS

Altay A. Y., Yavuz E., Bayram A., YAŞA C., Sözen H., Önder S.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.87, no.1, pp.54-60, 2024 (ESCI) Sustainable Development

8. The impact of intraoperative neural monitoring during papillary thyroid cancer surgery on completeness of thyroidectomy and thyroglobulin response: a propensity-score matched study

Iscan Y., Sengun B., Karatas İ., Atalay H. B., Sormaz İ. C., Onder S., et al.

ACTA CHIRURGICA BELGICA , vol.124, no.4, pp.298-306, 2024 (SCI-Expanded, Scopus) Sustainable Development

9. The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience

Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.

Turk Onkoloji Dergisi , vol.39, no.3, pp.257-264, 2024 (ESCI, Scopus, TRDizin)

10. Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.

Bagbudar S., KARANLIK H., Cabioglu N., Bayram A., Tükenmez M., AYDINER A., et al.

Medical oncology (Northwood, London, England) , vol.41, no.1, pp.18, 2023 (SCI-Expanded) Sustainable Development

11. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.

Journal of Cancer Research and Clinical Oncology , vol.149, no.16, pp.14833-14841, 2023 (SCI-Expanded, Scopus) Sustainable Development

12. Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer

Goksoy Solak Y., Yegen G., Onder S., Tekin S., SOYLUK SELÇUKBİRİCİK Ö., Gul N., et al.

ENDOCRINE , vol.82, no.2, pp.353-360, 2023 (SCI-Expanded, Scopus) Sustainable Development

13. The Role of Morphology in Predicting Fumarate Hydratase-deficient Uterine Leiomyomas in Young Women.

Bayram A., Bagbudar S., Sozen H., Onder S., Yavuz E.

Applied immunohistochemistry & molecular morphology : AIMM , 2023 (SCI-Expanded)

14. A Rare Diagnosis in a Virilized Adolescent with a 46,XX Karyotype: Gonadoblastoma with Dysgerminoma

KANDEMİR T., Ozturan E. K., DURAL Ö., ASLANGER A. D., İNAN BALCI E., BAYRAM A., et al.

HORMONE RESEARCH IN PAEDIATRICS , pp.559, 2023 (SCI-Expanded)

15. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas

Yegen G., ALTAY A. Y., Yılmaz İ., İŞCAN A. Y., Sormaz İ. C., Aksakal N., et al.

ENDOCRINE PATHOLOGY , vol.34, no.3, pp.279-286, 2023 (SCI-Expanded)

16. Evaluation of Benign Breast Diseases with or without Atypical Epithelial Hyperplasia Accompanying Radial Scars

Turkyilmaz Z., Sarisik E., Ozkurt E., Tukenmez M., Emiroglu S., Emiroglu B., et al.

European Journal of Breast Health , vol.19, no.2, pp.166-171, 2023 (Scopus)

17. Investigation of mRNA Expression Levels of Tip60 and Related DNA Repair Genes in Molecular Subtypes of Breast Cancer

Salihoğlu E., Demokan S., Karanlık H., Karahalil B., Önder S., Cömert S., et al.

Clinical Breast Cancer , vol.23, no.2, pp.125-134, 2023 (SCI-Expanded)

18. Surgery for phyllodes tumour of the breast. What should be surgical margins?

Tukenmez M., Mollavelioglu B., Onder S., Emiroglu S., VELİDEDEOĞLU M., ERGÜN S., et al.

ANZ Journal of Surgery , vol.93, no.1-2, pp.257-262, 2023 (SCI-Expanded)

19. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

CABIOĞLU N., BAYRAM A., EMİROĞLU S., ÖNDER S., Karatay H., Oner G., et al.

FRONTIERS IN ONCOLOGY , vol.13, 2023 (SCI-Expanded)

20. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes

Özkurt E., Emiroğlu S., Cabioğlu N., Karanlık H., Önder S., Tükenmez M., et al.

BREAST CARE , vol.17, no.6, pp.554-560, 2022 (SCI-Expanded) Sustainable Development

21. DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection

Onder S., Mete O., Yilmaz I., Bayram A., Bagbudar S., Altay A. Y., et al.

ENDOCRINE PATHOLOGY , vol.33, no.4, pp.437-445, 2022 (SCI-Expanded)

22. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer

MOLLAVELİOĞLU B., ÇETİN E., CABIOĞLU N., Abbasov A., ÖNDER S., EMİROĞLU S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.20, no.1, 2022 (SCI-Expanded, Scopus)

23. Ovarian and paraovarian adrenal rest tumors are not uncommon in gonadectomy materials of historical congenital adrenal hyperplasia cases in childhood

Yildiz M., Bayram A., BAŞ F., Karaman V., TOKSOY G., Poyrazoglu Ş., et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.187, no.1, 2022 (SCI-Expanded, Scopus)

24. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Tukenmez M., Emiroglu S., et al.

ANNALS OF SURGICAL ONCOLOGY , vol.29, no.SUPPL 1, pp.310-311, 2022 (SCI-Expanded, Scopus)

25. Prognostic Implications of Immune Infiltrates in the Breast Cancer Microenvironment: The Role of Expressions of CTLA-4, PD-1, and LAG-3

Bagbudar S., Karanlik H., Cabioglu N., Bayram A., Ibis K., Aydin E., et al.

Applied Immunohistochemistry and Molecular Morphology , vol.30, no.2, pp.99-107, 2022 (SCI-Expanded, Scopus) Sustainable Development

26. The effect of adenomyosis on endometrial cancer: a university hospital-based cohort study

Celik E., Goksever Celik H., Sozen H., Onder S., Tosun O. A., Topuz S., et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.1, pp.158-165, 2022 (SCI-Expanded) Sustainable Development

27. THE ROLE OF B LYMPHOCYTES AND PRESENCE OF GERMINAL CENTERS IN PATIENTS WITH LOCALIZED PROVOKED VULVODYNIA

Keles I. D., YAŞA C., ÖNDER S., Yavuz E., Tuzlali S., AKHAN S. E.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.85, no.1, pp.105-109, 2021 (ESCI)

28. Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment

Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.

BREAST CARE , vol.16, no.5, pp.468-474, 2021 (SCI-Expanded) Sustainable Development

29. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.19, no.1, 2021 (SCI-Expanded) Sustainable Development

30. Can histomorphological features predict lymph node metastasis in papillary thyroid microcarcinoma?

Gunduz M., Gunduz I. U., Gul N., Sormaz I. C., Aksakal N., Ozkan Z. G., et al.

VIRCHOWS ARCHIV , vol.479, no.SUPPL 1, 2021 (SCI-Expanded)

31. The role of FOXL2, SOX9, and beta-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary

Onder S., Hurdogan O., Bayram A., Yilmaz I., Sozen H., Yavuz E.

VIRCHOWS ARCHIV , vol.479, no.2, pp.317-324, 2021 (SCI-Expanded)

32. Childhood Rhabdomyosarcoma of the Female Genital Tract: Association with Pathogenic DICER1 Variation, Clinicopathological Features, and Outcomes

Kebudi R., Dural O., Bay S. B., Gorgun O., Onder S., Bilgic B., et al.

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY , vol.34, no.4, pp.449-453, 2021 (SCI-Expanded)

33. Loss of stromal CD73 expression plays a role in pathogenesis of polypoid endometriosis

Altay A. Y., Yavuz E., Bayram A., Yasa C., Akhan S. E., Topuz S., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.303, no.6, pp.1523-1530, 2021 (SCI-Expanded)

34. Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.

Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15, 2021 (SCI-Expanded, Scopus) Sustainable Development

35. TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

BMC CANCER , vol.21, no.1, 2021 (SCI-Expanded) Sustainable Development

36. Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?

Celik E., Kizildag Yirgin I., Goksever Celik H., Engin G., Sozen H., Ak N., et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.47, no.2, pp.560-569, 2021 (SCI-Expanded) Sustainable Development

37. Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

CANCER RESEARCH , vol.81, no.4, 2021 (SCI-Expanded) Sustainable Development

38. Differential expression of novel immune checkpoint receptors on tumor-infiltrating lymphocytes in patients with locally advanced breast cancer after neoadjuvant chemotherapy

Abbasov A., Aktas Cetin E., Cabioglu N., Mollavelioglu B., Onder S., Emiroglu S., et al.

NEOPLASMA , no.5, pp.1079-1090, 2021 (SCI-Expanded, Scopus)

39. Rhabdomyosarcoma of the Female Genital Tract : Long Term Outcome and Association With DICER1 Variation

Kebudi R., Buyukkapu S. B., Gorgun O., Yilmaz I., Bilgic B., Onder S., et al.

PEDIATRIC BLOOD & CANCER , vol.67, 2020 (SCI-Expanded)

40. Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)

Abbasov A., ÇETİN E., CABIOĞLU N., MOLLAVELİOĞLU B., ÖNDER S., EMİROĞLU S., et al.

CANCER RESEARCH , vol.80, no.16, 2020 (SCI-Expanded) Sustainable Development

41. Rhabdomyosarcoma of the female genital tract: Long-term outcome and association with DICER1 variation.

Kebudi R., Buyukkapu S. B., Gorgun O., Dural O., Onder S., Bilgic B., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15, 2020 (SCI-Expanded)

42. Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer

Kizildag Yirgin İ., Has D., Arslan G., Aydin E. C., Sari M., Onder S., et al.

EUROPEAN JOURNAL OF RADIOLOGY OPEN , vol.7, 2020 (ESCI) Sustainable Development

43. Does endometriosis have an effect on the survival of women with synchronous endometrial and ovarian cancer?

Celik E., Celik H. G., Sozen H., Onder S., Baktiroglu M., Topuz S., et al.

JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS , vol.11, no.4, pp.185-193, 2019 (ESCI) Sustainable Development

44. Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas

Turkyilmaz Z., Aydin T., Yilmaz R. S., Onder S., Ozkurt E., Tukenmez M., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , vol.15, pp.171-175, 2019 (ESCI)

45. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7, pp.777-780, 2019 (SCI-Expanded) Sustainable Development

46. Cystic Anastomosing Hemangioma of the Ovary: A Case Report With Immunohistochemical and Ultrastructural Analysis

Gunduz M., Hurdogan O., Onder S., Yavuz E.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY , vol.27, no.4, pp.437-440, 2019 (SCI-Expanded)

47. "Hidradenoma of the breast: Magnetic resonance (MR) imaging and ultrasonography (US) findings of this rare mass".

Yılmaz R. S., Tuncer S., Önder S., Cabıoğlu N., Acunas G.

The breast journal , vol.25, pp.314-315, 2019 (SCI-Expanded)

48. Synchronous metastatic leiomyosarcoma and primer invasive ductal carcinoma tumors in the same breast: Mammography, ultrasonography, and magnetic resonance imaging findings

Yilmaz R. S., Akpinar Y., Ozyavuz I., Onder S., Tukenmez M., Dursun M.

BREAST JOURNAL , vol.25, no.2, pp.310-311, 2019 (SCI-Expanded)

49. Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution

Sozen H., Vatansever D., Topuz S., Iyibozkurt C., Kandemir H., Yalcin I., et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.39, no.2, pp.253-258, 2019 (SCI-Expanded)

50. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer

Ozkurt E., Yardımcı E., Tukenmez M., Ersoy Y. E., Yilmaz R. S., Cabioglu N., et al.

BREAST JOURNAL , vol.25, pp.96-102, 2019 (SCI-Expanded) Sustainable Development

51. Distinguishing the progression of an endometrioma: Benign or malignant?

BAŞTU E., Onder S., Demiral I., Ozsurmeli M., Keskin G., TAKMAZ Ö., et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , vol.230, pp.79-84, 2018 (SCI-Expanded)

52. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.

Cabıoğlu N., Karanlık H., Kangal D., Ozkurt E., Öner G., Sezen F., et al.

Annals of surgical oncology , vol.25, pp.3030-3036, 2018 (SCI-Expanded)

53. Alışılmadık tiroid kitlesi: Tiroid bezinde izole tüberkülöz olgusu

Öztürk İ. E., Doruk C., Urla I., Önder S., Başaran B.

ENTcase , vol.4, no.3, pp.87-90, 2018 (Peer-Reviewed Journal)

54. Unilateral rapid enlargement of an adolescent breast: pseudoangiomatous stromal hyperplasia in a giant juvenile fibroadenoma

Bayramoglu Z., Yilmaz R. S., Caliskan E., Onder S., Akkavak G., Adaletli I.

BREAST JOURNAL , vol.24, no.4, pp.648-649, 2018 (SCI-Expanded)

55. Myofibroblastoma of the Breast: Ultrasonography, Mammography, and Magnetic Resonance Imaging Features With Pathologic Correlation

Yilmaz R. S., Akkavak G., Ozgur E., Onder S., Ozkurt E., Dursun M.

ULTRASOUND QUARTERLY , vol.34, no.2, pp.99-102, 2018 (SCI-Expanded)

56. High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.

Oner G., Önder S., Karatay H., Tükenmez M., Muslumanoglu M., Igci A., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.36, 2018 (SCI-Expanded) Sustainable Development

57. Encapsulated Papillary Carcinoma in A Man with Gynecomastia: Ultrasonography, Mammography and Magnetic Resonance Imaging Features with Pathologic Correlation

Yilmaz R. S., Comert R. G., Aliyev S., Toktas Y., Onder S., Emirikci S., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , vol.14, no.2, pp.127-131, 2018 (ESCI) Sustainable Development

58. Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase. study

GÜRAL Z., Saglam S., YÜCEL S., Kaytan-Saglam E., Asoglu O., Ordu C., et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY , vol.10, no.1, pp.40-47, 2018 (SCI-Expanded) Sustainable Development

59. MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses

YıLMAZ R. S., BAYRAMOGLU Z., EMIRIKÇI S., ÖNDER S., Salmaslıoğlu A., DURSUN M., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , no.1, pp.39-45, 2018 (ESCI) Sustainable Development

60. Investigation of expression levels of DNA repair genes in molecular subtypes of breast cancer.

Salihoğlu E., Demokan S., Karanlık H., Karahalil B., Önder S., Akaydın S.

journal of bioinformatics proteomics , vol.10, no.12, pp.1, 2017 (Peer-Reviewed Journal) Sustainable Development

61. A Selected Immunohistochemical Panel Aids in Differential Diagnosis and Prognostic Stratification of Subtypes of High-grade Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Study at a Single Institution

Taskin O. C., Onder S., Topuz S., Sozen H., Sen F., Ilhan R., et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.10, pp.696-702, 2017 (SCI-Expanded) Sustainable Development

62. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis

Onder S., Fayda M., Karanlik H., Bayram A., Sen F., Cabioglu N., et al.

BREAST JOURNAL , vol.23, no.6, pp.638-646, 2017 (SCI-Expanded) Sustainable Development

63. Correlation of F-18-FDG PET/CT with pathological features and survival in primary breast cancer

Has Simsek D., Sanli Y., Kuelle C. B., Karanlik H., Kilic B., Kuyumcu S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.38, pp.694-700, 2017 (SCI-Expanded, Scopus) Sustainable Development

64. High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium An immunohistochemical and clinicopathologic study

Onder S., Taskin O. C., Sen F., Topuz S., Kucucuk S., Sozen H., et al.

MEDICINE , vol.96, no.10, 2017 (SCI-Expanded)

65. Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study

Karanlik H., Kilic B., Yildirim I., Bademler S., Ozgur I., Ilhan B., et al.

BREAST CARE , vol.12, no.1, pp.29-33, 2017 (SCI-Expanded, Scopus)

66. Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: Findings likely to change treatment decisions

Karanlik H., Ozgur I., Kilic B., Fathalizadeh A., Sanli Y., Onder S., et al.

JOURNAL OF SURGICAL ONCOLOGY , vol.114, no.7, pp.796-802, 2016 (SCI-Expanded) Sustainable Development

67. Invasive carcinoma of no special type arising from an atypical microglandular adenosis of the breast: A case report and review of the literature

Onder S., OZKURT E., Tuzlali S., Ilhan R., Yavuz E.

VIRCHOWS ARCHIV , vol.469, 2016 (SCI-Expanded)

68. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors

Sari S. O., Taskin O. C., Gundogdu G., Yegen G., Onder S., Keskin M., et al.

ENDOCRINE PATHOLOGY , vol.27, no.2, pp.162-170, 2016 (SCI-Expanded)

69. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF(V600E) Harboring Pediatric Papillary Thyroid Carcinomas

Onder S., Sari S. O., Yegen G., Sormaz I. C., Yilmaz I., Poyrazoglu S., et al.

ENDOCRINE PATHOLOGY , vol.27, no.2, pp.153-161, 2016 (SCI-Expanded)

70. The Role of Ozone Therapy in Hepatic Fibrosis due to Biliary Tract Obstruction.

KOCAMAN H., ERGINEL B., ONDER S., Soysal F., Keskin E., ÇELIK A., et al.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie , vol.26, pp.133-7, 2016 (SCI-Expanded)

71. Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment

Aydiner A., Sen F., Tambas M., Ciftci R., Eralp Y., Saip P., et al.

MEDICINE , vol.94, no.52, 2015 (SCI-Expanded) Sustainable Development

72. Not All Post-FNA Spindle Cell Proliferations in the Thyroid Are of Myofibroblastic Origin: Follicular Adenoma with Spindle Cell Metaplasia

Yegen G., Buyuk M., Solmaz İ. C., Onder S., Ozturk S., Mete O.

ENDOCRINE PATHOLOGY , no.4, pp.374-376, 2015 (SCI-Expanded, Scopus)

73. Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery

Karanlik H., Ozgur I., Sahin D., Fayda M., Onder S., Yavuz E.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.13, 2015 (SCI-Expanded) Sustainable Development

74. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome

Karanlik H., Özgür I., Cabioglu N., Sen F., Erturk K., Kilic B., et al.

EJSO , vol.41, no.9, pp.1226-1233, 2015 (SCI-Expanded) Sustainable Development

75. Tumor Budding Is Independently Predictive for Lymph Node Involvement in Early Gastric Cancer

Gulluoglu M., Yegen G., Ozluk Y., Keskin M., Dogan S., Gundogdu G., et al.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY , vol.23, no.5, pp.349-358, 2015 (SCI-Expanded) Sustainable Development

76. Tongue metastasis of melanoma

Tas F., Karabulut S., Yegen G., Onder S., Ciftci R.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.11, no.3, 2015 (SCI-Expanded, Scopus)

77. Use of Antifibrotics to Prevent Ventriculoperitoneal Shunt Complications Due to Intra-abdominal Fibrosis: Experimental Study in a Rat Model.

Aydoseli A., Tahta A., Aras Y., Sabanci A., Keskin M., Balik E., et al.

Journal of neurological surgery. Part A, Central European neurosurgery , vol.76, no.3, pp.219-23, 2015 (SCI-Expanded) Sustainable Development

78. Clear cell sarcoma-like tumor of the gastrointestinal tract: a case report and review of the literature.

Yegen G., Gulluoglu M., Mete O., Onder S., Kapran Y.

International journal of surgical pathology , vol.23, no.1, pp.61-7, 2015 (SCI-Expanded)

79. Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury

Bal F., Bekpinar S., Unlucerci Y., Kusku-Kiraz Z., Onder S., Uysal M., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , vol.106, no.2, pp.295-302, 2014 (SCI-Expanded)

80. Guidelines for Extended Lymphadenectomy in Gastric Cancer: A Prospective Comparative Study

Asoglu O., Matlim T., KURT A., Onder S., Kunduz E., Karanlik H., et al.

ANNALS OF SURGICAL ONCOLOGY , vol.20, no.1, pp.218-225, 2013 (SCI-Expanded) Sustainable Development

81. Portal Gastropathy and Duodenopathy in Children With Extrahepatic and Intrahepatic Portal Hypertension: Endoscopic Diagnosis and Histologic Scoring

AYDOGAN A., Gulluoglu M., Onder S. Y., Gokce S., CELTIK C., Durmaz Ö.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION , vol.52, no.5, pp.612-616, 2011 (SCI-Expanded) Sustainable Development

82. Expression of KIR and C-type lectin receptors in Behcet's disease

SARUHAN-DIRESKENELI G., UYAR F. A., CEFLE A., ONDER S., EKSIOGLU-DEMIRALP E., KAMALI S., et al.

RHEUMATOLOGY , vol.43, no.4, pp.423-427, 2004 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 42

1. A rare case with an unusual location: immature teratoma of tongue in a fetus

Üzümcü A., Bayram A., Bağbudar S., Saraç Sivrikoz T., Önder S.

37th European Congress of Pathology, Vienna, Austria, 6 - 10 September 2025, vol.487, pp.487, (Summary Text)

2. Medullary thyroid carcinoma and pathogenic ret proto-oncogene variants in children: clinical outcomes following prophylactic/therapeutic thyroidectomy

Koç C., Yola Atalah Y. E., Yıldız M., Önder S., Yegen G., Aksakal N., et al.

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course, Kobenhavn, Denmark, 10 - 13 May 2025, vol.110, pp.106-107, (Summary Text)

3. Unexpected Foliage: Malignant Phyllodes Tumor In Male Breast

Kolik A. K., Bayram A., Önder S.

XXXV International Academy of Pathology Congress (IAP 2024), Cancun, Mexico, 27 - 31 October 2024, (Unpublished)

4. Extent of surgery in the surgical treatment of graves’ disease: subtotal vs. total thyroidectomy and comparison of the long-term results

ŞENGÜN B., İŞCAN A. Y., SORMAZ İ. C., AKSAKAL N., YEGEN G., ÖNDER S., et al.

46th Annual Meeting of the European Thyroid Association ETA, Atina, Greece, 7 - 10 September 2024, (Summary Text)

5. Malignancy in mature cystic teratomas: is it really rare? A single centre experience.

Üzümcü A., Bayram A., Sözen H., Önder S.

36th European Congress of Pathology, Florence, Italy, 7 - 11 September 2024, vol.485, pp.301, (Summary Text)

6. Contribution of 18F-FDG MAMMI-PET Imaging in Breast Cancer Staging

ASLANER K., HAS ŞİMŞEK D., ARSLAN D. F., YILMAZ R., ÖNDER S., CABIOĞLU N., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 19 - 23 October 2024, (Summary Text)

7. Is Biopsy Necessary for Thyroid Nodules Over 4 cm?

Gider İ., Vardar S., Şengün B., Karatas İ., İşcan A. Y., Önder S., et al.

23. Ulusal Cerrahi Kongresi, Antalya, Turkey, 24 April 2024, pp.1-2, (Summary Text) Sustainable Development

8. Baştan Cerrahi Uygulanan Erken Evre Multifokal/Multisentrik Meme Kanserinde MemeKoruyucu Cerrahinin Onkolojik Güvenilirliği

, Doylu A., Mollavelioğlu B., Emiroğlu S., Tükenmez M., Yılmaz R. S., et al.

23. Ulusal Cerrahi Kongresi , Antalya, Turkey, 24 - 28 April 2024, (Unpublished)

9. ÜÇLÜ NEGATİF MEME KANSERİ FFPE ÖRNEKLERİNDEN İZOLE EDİLEN DNA’NIN YENİ NESİL DİZİLEME İÇİN MİKTAR VE KALİTESİNİN ÖLÇÜMÜNDE FARKLI METODLARIN DEĞERLENDİRİLMESİ

Şen M., Manto K., Özdemir Ö., Tokat F., Önder S., Özbek U., et al.

2. ULUSLARARASI 27. ULUSAL FARMAKOLOJİ KONGRESİ , Antalya, Turkey, 23 - 26 November 2023, pp.318, (Summary Text)

10. Granüloza hücreli tümörlerde nüksü öngörebilir miyiz?

Bayram A., Bağbudar S., Sözen H., Yavuz E., Önder S.

32. Ulusal Patoloji Kongresi, Antalya, Turkey, 25 - 29 October 2023, pp.1, (Summary Text)

11. MEMENİN MEZENKİMAL TÜMÖRLERİ

Cantürk Z., Bayram A., Bağbudar S., Ünverengil G., Bilgiç M. B., Önder S.

32. ULUSAL PATOLOJİ KONGRESİ, Antalya, Turkey, 25 - 29 October 2023, vol.7, pp.483, (Summary Text)

12. Basedow Graves Zemininde Gelişen Papiller Tiroid Kanseri Agresif Histopatoloji Ve Kötü Prognoz İle İlişkili Midir?

Güden İ., Karataş İ., İşcan A. Y., Yegen G., Önder S., Sormaz İ. C., et al.

11. Ulusal Endokrin Cerrahi Kongresi, Antalya, Turkey, 16 - 19 March 2023, pp.102, (Summary Text)

13. GENÇ YAŞTA SAPTANAN LEİOMYOMLAR VE FUMARAT HİDRATAZ EKSPRESYON KAYBI İLİŞKİSİ. LEİOMYOSARKOMLAR BU DENKLEMİN NERESİNDE?

Bayram A., Önder S., Sözen H., Yavuz E.

31. Ulusal Patoloji Kongresi, İzmir, Turkey, 26 - 30 October 2022, pp.165, (Summary Text)

14. MİKROGLANDÜLER ADENOZİS ZEMİNİNDE GELİŞMİŞ KONDROMİKSOİD MATRİKS ÜRETEN METAPLASTİK KARSİNOM

Karaoğlan Ç. Ş., Bayram A., Önder S., Yavuz E.

31. Ulusal Patoloji Kongresi, İzmir, Turkey, 26 - 30 October 2022, pp.441, (Summary Text)

15. Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer

DOĞAN İ., Aydın E., PAKSOY N., FERHATOĞLU F., AK N., İBİŞ K., et al.

ASCO 2021, United States Of America, 04 June 2021, (Summary Text)

16. MEME KANSERLİ HASTALARDA NEOADJUVAN TEDAVİ SONRASI PATOLOJİK YANITIN ÖNGÖRÜLMESİNDE 18F-FDG PET/BT’NİN ROLÜ

Oflas M., Has Şimşek D., Işık E. G., Emirikçi S., Cabıoğlu N., Müslümanoğlu M. E., et al.

33. Ulusal Nükleer Tıp Kongresi, İstanbul, Turkey, 28 - 29 May 2021, pp.10-11, (Summary Text)

17. ÖNEMİ BELİRSİZ ATİPİ/ÖNEMİ BELİRSİZ FOLİKÜLER LEZYON (AUS/FLUS): SİTOLOJİK VE HİSTOPATOLOJİK KORELASYON, FARKLI SİTOLOJİK ALT TİPLERDE MALİGNİTE RİSKLERİNİN KARŞILAŞTIRILMASI

Özdemir H., Vurallı Bakkaloğlu D., Yegen G., Önder S., Yılmazbayhan D., Özlük M. Y.

9. ULUSAL SİTOPATOLOJİ SANAL KONGRESİ, Ankara, Turkey, 26 - 28 March 2021, pp.64-65, (Summary Text)

18. Kornea rejeksiyonunda dokudaki ve aköz humordeki immünolojik değişikliklerin detaylı incelelmesi: İmmünohistokimya, flow sitometri ve solubil reseptörler

Çetin E., Esen F., Genç S., Önder S., Aykut V., Taşkapılı M., et al.

TOD 54. Ulusal Kongresi (Online kongre), 9 - 13 December 2020, pp.1-2, (Full Text)

19. DICER1 Hotspot Mutations in Pediatric Thyroid Papillary Carcinoma: A Single Center Experience.

ÖNDER S., Yilmaz I., Bayram A., Issin G., Terzi N. K., Iscan Y., et al.

109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los-Angeles, Chile, 29 February - 05 March 2020, vol.100, pp.589-591, (Summary Text)

20. Differential expression of novel immune checkpoint receptors expressed on tumor-infiltrating lymphocytes (TIL) in patients with early breast cancer

MOLLAVELİOĞLU B., Cetin E. A., CABIOĞLU N., Abbasov A., ÖNDER S., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 10 - 14 December 2019, vol.80, (Summary Text) Sustainable Development

21. Outcomes of pediatric thyroidectomy in a tertiary hospital

İşcan A. Y., Sormaz İ. C., Batman B., Yegen G., Önder S., Tunca F., et al.

Türk katılımlı Yunanistan Cerrahi Kongresi, Athens, Greece, 22 - 24 November 2019, pp.25, (Summary Text) Sustainable Development

22. ERKEN EVRE MEME KANSERLİ HASTALARDA TÜMÖR İNFİLTRE EDEN LENFOSİTLERDE YENİ NESİL İMMÜN KONTROL NOKTASI RESEPTÖRLERİNİN EKSPRESYONU

MOLLAVELİOĞLU B., ÇETİN E., CABIOGLU N., Abbasov A., ÖNDER S.

15. Ulusal Meme Hastalıkları Kongresi, Antalya, Turkey, 6 - 10 November 2019, pp.76, (Full Text) Sustainable Development

23. LOKAL İLERİ MEME KANSERLİ HASTALARDA NEOADJUVAN KEMOTERAPİ SONRASI PD-1, CTLA-4 POZİTİF TÜMÖR İNFİLTRE EDEN LENFOSİT EKSPRESYONUNUN KLİNİK ÖNEMİ VARMI?

Abbasov A., ÇETİN E., CABIOGLU N., MOLLAVELİOĞLU B., ÖNDER S., EMİROĞLU S., et al.

15. Ulusal Meme Hastalıkları Kongresi, Antalya, Turkey, 6 - 10 November 2019, pp.109, (Full Text) Sustainable Development

24. VON HIPPEL-LINDAU SENDROMLU, MULTIORGAN TUTULUMLU HASTA: OLGU SUNUMU

Büyük M., Gündüz I., Önder S., Yavuz E., Güllüoğlu M.

29. Ulusal Patoloji Kongresi, Trabzon, Turkey, 23 - 26 October 2019, vol.3, pp.206-207, (Summary Text)

25. Tiroid Lobektomiye Uygun Olarak Değerlendirilen 1-4 Cm Papiller Tiroid Kanserinde Histopatolojik Verilere Göre Tamamlayıcı Tiroidektomi Oranı.

Çelik A., Abbasov A., SORMAZ İ. C., Batman B., YEGEN G., ÖNDER S., et al.

9. Ulusal Endokrin Cerrahi Kongresi, Antalya, Turkey, 2 - 05 May 2019, pp.46, (Summary Text) Sustainable Development

26. DİFERANSİYE PAPİLLER TİROİD KANSERLERİNDE METASTAZ RİSKİ, NÜKS VE SAĞKALIMI BELİRLEMEDE TRANSGLUTAMİNAZ 2 EKSPRESYONUNUN ROLÜ

Göksoy Solak Y., Önder S., Yegen G., Soyluk Selçukbiricik Ö., Gül N., Kubat Üzüm A., et al.

41.Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi , Antalya, Turkey, 27 April - 01 May 2019, pp.127-128, (Summary Text) Sustainable Development

27. REJECTION IN AN IMMUNE PRIVILEGED TISSUE: CHARACTERISTICS OF IMMUNE CHECKPOINTS AND LYMPHOCYTE SUBSETS IN CORNEAL REJECTION

ESEN F., Genç S., ÖNDER S., Karadağ R., Aykut V., Demirok A., et al.

International Molecular Immunology & Immunogenetics Congress IV ( MIMIC IV), Bursa, Turkey, 27 - 29 April 2019, vol.QA133, pp.31, (Summary Text)

28. REJECTİON IN AN IMMUNE PRIVILEGED TISSUE: CHARACTERISTICS OF IMMUNE CHECKPOINTS AND LYMPHOCYTE SUBSETS IN CORNEAL REJECTION

ESEN F., GENÇ S., ÖNDER S., KARADAG R., AYKUT V., DEMİROK A., et al.

INTERNATIONAL MOLECULAR IMMUNOLOGY IMMUNOGENETICS CONGRESS IV (MIMIC IV), 27 - 29 April 2019, (Full Text)

29. Ektopik Yerleşimli Paratiroid Adenomların Preoperatif Lokalizasyonunda Tc-99m MIBI SPECT/BT’nin Katkısı

ENGİN M. N., HAS ŞİMŞEK D., ŞENYÜREK Y., ÖNDER S., ÜNAL S. N.

31. ULUSAL NÜKLEER TIP KONGRESİ, Bodrum, Turkey, 10 - 14 April 2019, vol.1, pp.63-64, (Summary Text)

30. Improved false negative rates with intra-operative identification of clipped nodes in patients undergoing SLNB after neoadjuvant chemotherapy

Cabioglu N., Karanlk H., Kangal D., Ozkurt E., Tukenmez M., Ylmaz R., et al.

19th Annual Meeting of the American-Society-of-Breast-Surgeons, Florida, United States Of America, 2 - 06 May 2018, vol.25, pp.433, (Summary Text)

31. Sürrenalin IgG4 ilişkili kalsifiye fibröz tümörü: Olgu sunumu.

KARATAY H., YEGEN G., SÜNNETÇİOĞLU E., AKSAKAL N., ARAL F., BİLGİÇ M. B., et al.

27. Ulusal Patoloji Kongresi, Antalya, Turkey, 15 - 18 November 2017, pp.176, (Full Text)

32. Tümör içinde tümör; feokromositomaya osteosarkom metastazı: Olgu sunumu.

KARATAY H., GÖRGÜN Ö. D., SORMAZ İ. C., ÖNDER S., BİLGİÇ M. B., YEGEN G.

27. Ulusal Patoloji Kongeresi, Antalya, Turkey, 15 - 18 November 2017, pp.162, (Full Text)

33. Umblikal Kordon Teratomu-Vaka Sunumu

Güngör Uğurlucan F., Demir Ö., Saraç Sivrikoz T., Has R., Önder S., Yüksel A.

TMFP Ultrason Kursu, İstanbul, Turkey, 2 - 04 November 2017, pp.51, (Full Text)

34. Clinicopathological Characteristics of Nipple Discharge-Associated Breast Cancer

Cabioglu N., Bender O., Ergozen F., Ozkurt E., Tukenmez M., Balci F., et al.

17th Annual Meeting of the American-Society-of-Breast-Surgeons, Texas, United States Of America, 13 - 17 April 2016, vol.23, pp.43-44, (Summary Text) Sustainable Development

35. Nüks meme kanserinde reoperatif sentinel lenf nodu biyopsisi: Aksilla korunabilir mi?

Karanlık H., Özgür İ., Kılıç B., Şanlı Y., Önder S., Taştekin D., et al.

13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Turkey, 21 - 25 October 2015, pp.1, (Summary Text) Sustainable Development

36. THE ROLE OF OZONE THERAPY IN HEPATIC FIBROSIS DUE TO BILIARY TRACT OBSTRUCTION

KOCAMAN O. H., ERGİNEL B., ÖNDER S., GÜN SOYSAL F., KESKİN E., ÇELİK A., et al.

16th Congress of the European Paediatric Surgeons’ Association (EUPSA), Ljubljana, Slovenia, 17 - 20 June 2015, (Summary Text)

37. Clinical distuingishing characteristics and management of phyllodes tumors of the breast.

Tukenmez M., Kulle C. B., Velidedeoglu M., Agcaoglu O., Parlakgul G., Aydogan F., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text)

38. GRANÜLOMATÖZ ALANLAR İÇEREN İNTRAHEPATİK LENFOEPİTELYOMA BENZERİ KOLANJİOKARSİNOM OLGU SUNUMU

YEGEN G., BİLGİÇ A., ÖNDER S., DEMİR K., EKİZ F., DOĞAN İ. Ö., et al.

24. ULUSAL PATOLOJİ KONGRESİ, Trabzon, Turkey, 19 - 23 November 2014, (Summary Text)

39. EKSTRANODALROSAİ DORFMAN HASTALIĞI: YAYGIN NODÜLER GASTROİNTESTİNAL KANAL TUTULUMU VE NÜKSLERLE SEYREDEN BAŞ BOYUN TUTULUMU GÖSTEREB 2 OLGU

ÖNDER S., ÖZTÜRK SARI Ş., AYNI E. B., YEGEN G., GÜLLÜOĞLU M., KAPRAN Y., et al.

24. ULUSAL PATOLOJİ KONGRESİ, Trabzon, Turkey, 19 - 23 June 2014, pp.837, (Full Text)

40. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144, (Summary Text)